Feature

Scaling Science: My Precision Medicine Accessibility Mission

Sitting Down With… Luca Quagliata, Vice President and Global Head of Medical Affairs at Thermo Fisher Scientific

Share

  • 1

    Transitioned from academia to industry for greater impact.

  • 2

    Emphasizes a people-first leadership style.

  • 3

    Stresses the importance of continuous learning.

  • 4

    Advocates for collaboration in precision medicine.

  • 5

    Believes in social responsibility in industry.

  • 6

    Aims for accessible solutions for all patients.

  • 7

    Views leadership as enabling decision-making by teams.

  • 8

    Considers broader perspectives essential for professionals.

Original Source(s)

Scaling Science: My Precision Medicine Accessibility Mission

Sitting Down With… Luca Quagliata, Vice President and Global Head of Medical Affairs at Thermo Fisher Scientific

  • by Helen Bristow

  • February 3, 2026

  • 6 min

Related Content

Can a BiTE Immunotherapy Improve Survival in Young Patients with High-Risk Kinase-Driven B-ALL Subtypes?

Two genetic subtypes of childhood B-cell acute lymphoblastic leukemia (B-ALL) have long been associated with inferior treatment outcomes: Philadelphia chromosome-positive (Ph+) and ABL-class Philadelphia chromosome-like (Ph-like) B-ALL.

  • by

  • January 29, 2026

  • 3 min
What Should Doctors Know About FDA’s Black Box Change for Hormone Replacement Therapy Drugs?

A Keck Medicine of USC breast surgeon discusses the FDA’s decision — and whether using HRT to treat menopause symptoms actually affects breast cancer risk.

  • by

  • January 28, 2026

  • 8 min
Cellares and City of Hope to Automate Manufacturing of Solid Tumor CAR T Cell Therapy

Collaboration addresses solid tumor manufacturing bottlenecks and accelerates advancement toward clinical trials

  • January 27, 2026

  • 3 min